ÃÑ 260ÆäÀÌÁö
3ÆäÀÌÁö º»¹®½ÃÀÛ
1. Mouse Hepatitis Virus (MHV) and its related mouse model fro SARS-CoV-2 ¡¤¡¤¡¤¡¤ 1
°æºÏ´ëÇб³ ¾àÇдëÇÐ °È¿Á¤ ±³¼ö
2. A platform technology for delivery of nucleic acids and proteins¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 47
Áß¾Ó´ëÇб³ ÀÚ¿¬°úÇдëÇÐ ¿°ÁöÇö ¹Ú»ç
3. °¡ÃàÁúº´¿¬±¸¿¡ Àû¿ë °¡´ÉÇÑ »ý¹°Á¤º¸ ºÐ¼®¹ý ¼Ò°³¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 72
±¹¸³Ãà»ê°úÇпø µ¿¹°À¯Àüü°ú äÇÑÈ ¹Ú»ç
4. °øµ¿Àåºñ ¹× BSC ÀÌ¿ëÀÚ ±³À°¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤
91
¢ßºñ¿¡½º·¦ ÀüÅ¿ø ´ëÇ¥
5. Prion genetics in animals¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤
117
ÀüºÏ´ëÇб³ Àμö°øÅëÀü¿°º´¿¬±¸¼Ò Á¤º´ÈÆ ±³¼ö
6. ¸»ÀÇ ¹ø½ÄÀÇ Á߿伺 ¹× »ê°ú Áúȯ¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 151
Á¦À̾ؾ¾µ¿¹°º´¿ø ȲÁؼ® ¼öÀÇ»ç
7. ±âÈĺ¯È¿¡ µû¸¥ Àü¿°º´ ¸Å°³ ¸ð±â¿Í Áúº´À¯ÀÔ¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 171
°æºÏ´ëÇб³ ÀÚ¿¬°úÇдëÇÐ ÃÖ±¤½Ä ±³¼ö
8. Áúº´ Á¦¾î¸¦ À§ÇÑ ´Ü¹éÁú 3Â÷¿ø ±¸Á¶ ÅëÇÕ ºÐ¼® ±â¼ú¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 191
Çѱ¹±âÃÊ°úÇÐÁö¿ø¿¬±¸¿ø ±èÇý¿¬ ¼±ÀÓ¿¬±¸¿ø
9. Global control of ASF; A GF-TADs initiative¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 217
³ó¸²Ãà»ê°Ë¿ªº»ºÎ ÇØ¿ÜÀü¿°º´°ú ¼öÀÇ¿¬±¸°ü ¹ÚÁö¿ë
10. ASFV research in FRCVAM, Russia¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 241
Federal Research Center for Virology and Microbiology Titov I.A.
°æºÏ´ëÇб³ ¾àÇдëÇÐ °È¿Á¤ ±³¼ö
2. A platform technology for delivery of nucleic acids and proteins¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 47
Áß¾Ó´ëÇб³ ÀÚ¿¬°úÇдëÇÐ ¿°ÁöÇö ¹Ú»ç
3. °¡ÃàÁúº´¿¬±¸¿¡ Àû¿ë °¡´ÉÇÑ »ý¹°Á¤º¸ ºÐ¼®¹ý ¼Ò°³¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 72
±¹¸³Ãà»ê°úÇпø µ¿¹°À¯Àüü°ú äÇÑÈ ¹Ú»ç
4. °øµ¿Àåºñ ¹× BSC ÀÌ¿ëÀÚ ±³À°¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤
91
¢ßºñ¿¡½º·¦ ÀüÅ¿ø ´ëÇ¥
5. Prion genetics in animals¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤
117
ÀüºÏ´ëÇб³ Àμö°øÅëÀü¿°º´¿¬±¸¼Ò Á¤º´ÈÆ ±³¼ö
6. ¸»ÀÇ ¹ø½ÄÀÇ Á߿伺 ¹× »ê°ú Áúȯ¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 151
Á¦À̾ؾ¾µ¿¹°º´¿ø ȲÁؼ® ¼öÀÇ»ç
7. ±âÈĺ¯È¿¡ µû¸¥ Àü¿°º´ ¸Å°³ ¸ð±â¿Í Áúº´À¯ÀÔ¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 171
°æºÏ´ëÇб³ ÀÚ¿¬°úÇдëÇÐ ÃÖ±¤½Ä ±³¼ö
8. Áúº´ Á¦¾î¸¦ À§ÇÑ ´Ü¹éÁú 3Â÷¿ø ±¸Á¶ ÅëÇÕ ºÐ¼® ±â¼ú¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 191
Çѱ¹±âÃÊ°úÇÐÁö¿ø¿¬±¸¿ø ±èÇý¿¬ ¼±ÀÓ¿¬±¸¿ø
9. Global control of ASF; A GF-TADs initiative¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 217
³ó¸²Ãà»ê°Ë¿ªº»ºÎ ÇØ¿ÜÀü¿°º´°ú ¼öÀÇ¿¬±¸°ü ¹ÚÁö¿ë
10. ASFV research in FRCVAM, Russia¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 241
Federal Research Center for Virology and Microbiology Titov I.A.
3ÆäÀÌÁö º»¹®³¡
¸Þ´º
ÇöÀç Æ÷Ä¿½ºÀÇ ¾Æ·¡³»¿ëµéÀº µ¿ÀÏÇÑ ÄÁÅÙÃ÷¸¦ °¡Áö°í ÆäÀÌÁö³Ñ±è È¿°ú¹× ½Ã°¢Àû È¿°ú¸¦ Á¦°øÇÏ´Â ÆäÀÌÁöÀ̹ǷΠ½ºÅ©¸°¸®´õ »ç¿ëÀÚ´Â ¿©±â±îÁö¸¸ ³¶µ¶ÇϽðí À§ÀÇ ÆäÀÌÁöÀ̵¿ ¸µÅ©¸¦ »ç¿ëÇÏ¿© ´ÙÀ½ÆäÀÌÁö·Î À̵¿ÇϽñ⠹ٶø´Ï´Ù.